IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
AnemiaColorectal Neoplasm
Interventions
DRUG

Ferric carboxymaltose

A minimum of 1 dose of 1000mg of intravenous ferric carboxymaltose will be administered at least 14 days prior to the date of operation.

DRUG

Ferrous Sulphate

(Control) 200mg twice a day of oral ferrous sulphate will be administered for a minimum of a two week period

Trial Locations (8)

NG7 2UH

Nottingham University Hospitals NHS Trust, Nottingham

B15 2TH

University Hospital Birmingham, Birmingham

WV10 0QP

Royal Wolverhampton Hospitals NHS Trust, Wolverhampton

BS2 8HW

University Hospitals Bristol Foundation NHS Turst, Bristol

DE22 3NE

Derby Hospital NHS Foundation Trust, Derby

LS9 7TF

St James University Hospitals NHS Trust, Leeds

LE1 5WW

University Hospitals of Leicester NHS Trust, Leicester

BA21 4AT

Yeovil District Hospital NHS Foundation Trust, Yeovil

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Nottingham University Hospitals NHS Trust

OTHER

NCT01701310 - IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia | Biotech Hunter | Biotech Hunter